Up for grabs: Q&M offers 1-for-5 rights issue

It’s an attractive 140.5 million shares at $0.10/rights share.

Dental group Q&M has announced a 1-for-5 rights issue to raise $14.1 million. Major shareholders Quan Min Holdings and the CEO Dr Ng hold a combined stake of 65.2% and have agreed to take up their rights entitlements and fully subscribe to their allotments.

A report by Maybank indicates that the rights issue price is very attractive given the stock’s outperformance and the expected positive contributions from Q&M’s China acquisitions. The major shareholders’ decision to fully subscribe for their allotments is also a strong endorsement of the stock. Maybank expects the funds raised to be used to complete 2 other acquisitions (Aoxin and Aidite).

The full year impact from the acquisitions will be felt only in FY15E, and more EPS-accretive acquisitions are expected in the future, beyond the 6 announced acquisitions (5 in China, 1 in Singapore).

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia